- Record: found
- Abstract: not found
- Article: not found
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A 2005 interim analysis of the Bypass versus Angioplasty in Severe Ischaemia of the
Leg (BASIL) trial showed that in patients with severe lower limb ischemia (SLI; rest
pain, ulceration, gangrene) due to infrainguinal disease, bypass surgery (BSX)-first
and balloon angioplasty (BAP)-first revascularization strategies led to similar short-term
clinical outcomes, although BSX was about one-third more expensive and morbidity was
higher. We have monitored patients for a further 2.5 years and now report a final
intention-to-treat (ITT) analysis of amputation-free survival (AFS) and overall survival
(OS).